Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Onto Innovation Inc ONTO

Onto Innovation Inc. is engaged in the design, development, manufacture and support of metrology and inspection tools for the semiconductor industry. The Company’s products include Automated Metrology Systems; Integrated Metrology Systems; Silicon Wafer All-surface Inspection/Characterization; Macro Defect Inspection; Automated Defect Classification and Pattern Analysis; Yield Analysis; Opaque... see more

Recent & Breaking News (NYSE:ONTO)

Nanobiotix renforce son équipe dirigeante aux Etats-Unis avec le recrutement d’un Directeur du Développement Clinique et une Directrice des Relations Investisseurs

Business Wire October 3, 2016

Nanobiotix Strengthens U.S. Leadership with Appointments of Head of U.S. Clinical Development and Director of Investor Relations

Business Wire October 3, 2016

Nordic Nanovector: Safety Review Committee supports dose escalation with Betalutin® in Lymrit 37-01 trial pending safety data from cohort receiving higher pre-dosing

Business Wire September 23, 2016

Nordic Nanovector ASA – Changes to the Board of Directors and Notice of Extraordinary General Meeting

Business Wire September 21, 2016

Bpifrance accorde un prêt de 2M€ à taux zéro à Nanobiotix pour accompagner la dernière phase de développement du produit NBTXR3

Business Wire September 19, 2016

Bpifrance Grants Nanobiotix a 2M€ Interest-Free Loan to Support Final Development Stage of Lead Product, NBTXR3

Business Wire September 19, 2016

Bpifrance grants Nanobiotix a 2MEU interest-free loan to support final development stage of lead product, NBTXR3

GlobeNewswire September 19, 2016

Nanobiotix dépose sa première demande d’autorisation de mise sur le marché (marquage CE) pour son produit NBTXR3

Business Wire September 13, 2016

Nanobiotix announces submission for first market approval of lead product NBTXR3 in Europe

Business Wire September 13, 2016

Nordic Nanovector ASA – Notification of Share Capital Increase

Business Wire September 13, 2016

Nanobiotix : Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social

Business Wire September 7, 2016

Nordic Nanovector: Lilotomab Pre-Dosing of NHL Patients before Betalutin® Therapy Lowers Haematological Toxicity with No Reduction in the Tumor Absorbed Radiation Dose

Business Wire September 5, 2016

NANOBIOTIX : Mise à disposition du Rapport Financier Semestriel

Business Wire September 1, 2016

Nanobiotix Half Year Results for the Six Months Ended 30 June 2016

Business Wire August 31, 2016

NANOBIOTIX : Résultats semestriels au 30 juin 2016

Business Wire August 31, 2016

NORDIC NANOVECTOR ASA - FINANCIAL CALENDAR

Business Wire August 31, 2016

NORDIC NANOVECTOR ASA – MANDATORY NOTIFICATION OF TRADE/ISSUANCE OF NEW SHARES

Business Wire August 30, 2016

NORDIC NANOVECTOR ASA – MANDATORY NOTIFICATION OF TRADE

Business Wire August 25, 2016

Nordic Nanovector ASA – Results for Second Quarter and Half Year 2016

Business Wire August 24, 2016

NOTIFICATION OF MAJOR INTEREST IN SHARES

UK Regulatory news services, from the LSE August 18, 2016